快速使用未稀释的 levetiracetam 加载剂量
Sydni Martinez1, Sophia S Bonnin1, John Radosevich1
1Department of Pharmacy, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Epilepsia
|December 20, 2023
概括
快速注射未稀释的 levetiracetam (LEV) 到 4500 毫克静脉注射是安全的,并且可以很好地容忍状态治疗. 这项研究支持更高的LEV剂量,以更快地控制发作.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 状态需要快速服用抗发作药物.
- 目前关于未稀释的 levetiracetam (LEV) 负载剂量的现有数据仅限于2500 mg以上.
- 更高的LEV剂量可能会提高控制速度.
研究的目的:
- 为了评估快速静脉注射 (IV) 的安全性和耐受性,在2500毫克至4500毫克的负载剂量下推送未经稀释的LEV.
- 评估在临床实践中使用更高LEV剂量的可行性.
主要方法:
- 成年患者的回顾性观察队列分析.
- 纳入标准:至少接受了一剂未经稀释的IV推送LEV (2500-4500毫克) 的充满剂量.
- 在一个大型学术医疗中心从2019年10月到2022年4月收集的数据.
主要成果:
- 分析了518名患者的518个负载剂量.
- 平均LEV负载剂量为3600毫克;最常见的是4000毫克.
- 没有记录LEV给药时出现的不良事件.
- 在78.6%的病例中使用了外围静脉输液线.
结论:
- 2500-4500毫克的未稀释LEV的快速静脉注射是安全的和可以容忍的.
- 这种方法促进了 status epilepticus 的快速药物输送.
- 支持使用更高的LEV剂量来有效控制发作.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
307
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
307
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Delivery: Parenteral Route
545
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
545
Antiepileptic Drugs: Potassium Channel Activators
184
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
184
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K


